Prelude Therapeutics Inc (PRLD) — Defensive Interval Ratio
Prelude Therapeutics Inc (PRLD) has a Defensive Interval Ratio of 149 days as of September 2025. Defensive assets of $7.42 Million (cash $-, short-term investments $7.42 Million, receivables $-) cover 149 days of daily cash needs of $49.84K/day. See PRLD working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Prelude Therapeutics Inc Defensive Interval Ratio (2020–2024)
This chart shows how Prelude Therapeutics Inc's Defensive Interval Ratio has evolved across 5 annual periods from 2020 to 2024. As of September 2025, the ratio stands at 149 days, meaning defensive assets of $7.42 Million can fund 149 days of operations without new revenue. See how leveraged is Prelude Therapeutics Inc's balance sheet to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Prelude Therapeutics Inc (2020–2024)
The table below presents the year-by-year Defensive Interval Ratio for Prelude Therapeutics Inc from 2020 to 2024, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Prelude Therapeutics Inc market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 1724 days | $121.14 Million | $70.25K/day | $- | $121.14 Million | ▼ -1748 days |
| 2023 | 3472 days | $207.64 Million | $59.81K/day | $- | $207.64 Million | ▲ +594 days |
| 2022 | 2878 days | $171.12 Million | $59.46K/day | $- | $171.12 Million | ▼ -2053 days |
| 2021 | 4931 days | $259.40 Million | $52.61K/day | $- | $259.40 Million | ▲ +4931 days |
| 2020 | 0 days | $0.00 | $31.16K/day | $- | $0.00 | — |